Tezkor likvidlik koeffitsiyenti: Qiagen N.V. (QGEN)

Qiagen NV - QGEN emitenti grafik logotipi

Tezkor koeffitsient Qiagen N.V. (QGEN) kompaniyasining zudlik bilan to'lov qobiliyatini ko'rsatadi, bunda oxirgi ko'rsatkich 2.26 ni tashkil etadi. Kompaniyaning biznes modeli "razor-and-blade" prinsipiga asoslangan bo'lib, bunda uskunalar faqatgina maxsus reagentlar bilan ishlaydi. Bunday molekulyar diagnostika ekotizimi mijozlar uchun yuqori o'tish xarajatlarini yuzaga keltiradi. Akademik budjetlardagi ehtimoliy tebranishlarga qaramay, sarf materiallariga bo'lgan talab barqaror daromadni ta'minlaydi.

Qiagen NV (QGEN) - Kritik likvidlik 04.07.2022dan 30.10.2026gacha
Qiagen NV ishlab chiqargan mahsulot

Qiagen N.V. (QGEN) kompaniyasining tashqi zarbalarga bardosh berish qobiliyati zudlik bilan foydalanish mumkin bo'lgan aktivlarning mavjudligiga bog'liq. COVID testlaridan tushumlarning kamayishi va DNK tahlilidagi qimmat ishlanmalarni hisobga olgan holda, naqd pul zaxirasini saqlash juda muhimdir. Ushbu ko'rsatkich illikvid inventarlarni istisno qilgan holda, majburiyatlarning qoplanishini faqat naqd pul va debitorlik qarzlari orqali baholaydi. Yakuniy tezkor ko'rsatkichni tahlil qilish orqali investor ombor zaxiralarini hisobga olmasdan, biznesning real to'lov qobiliyatini aniqlashi mumkin.

Muhim raqobatchilar

TEM: Tezkor likvidlik koeffitsiyenti|IONS - Oraliq qoplama koeffitsiyenti|RGEN (Repligen Corporation) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti aviditybiosciences.com|Tezkor likvidlik koeffitsiyenti CRSP|GeneDx Holdings (WGS) - Kritik likvidlik|Tezkor likvidlik koeffitsiyenti RARE (Ultragenyx Pharma)|Beam Tx (BEAM) - Shoshilinch likvidlik|SRPT - Tezkor likvidlik|TWST (twistbioscience.com) - Shoshilinch likvidlik koeffitsiyenti|TXG (10x Genomics) - Tezkor likvidlik ko‘rsatkichi|Intellia Therapeutics Inc - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Stoke|Shoshilinch likvidlik koeffitsiyenti BLFS (BioLife)|Tezkor likvidlik ko‘rsatkichi WVE (Wave Life Sciences)|Oraliq qoplama koeffitsiyenti mazetx.com|Sionna Therapeutics - Tezkor likvidlik ko‘rsatkichi|Prime Medicine Inc - Tezkor likvidlik|TSHA: Tezkor likvidlik ko‘rsatkichi|Oraliq qoplama koeffitsiyenti uniQure Pharma QURE|MeiraGTx Holdings plc (MGTX) - Tezkor likvidlik|Kritik likvidlik regenxbio.com RGNX|SLDB (Solid Biosciences) - Tezkor likvidlik koeffitsiyenti|OCGN - Kritik likvidlik|Tezkor likvidlik koeffitsiyenti PACB|BNTC - Shoshilinch likvidlik|Tezkor likvidlik Design Therapeutics DSGN|RCKT: Shoshilinch likvidlik koeffitsiyenti|4D Molecular Therapeutics, Inc. - Tezkor likvidlik koeffitsiyenti|LXEO (Lexeo Therapeutics) - Shoshilinch likvidlik koeffitsiyenti|korrobio.com (KRRO) - Tezkor likvidlik|Shoshilinch likvidlik koeffitsiyenti EDIT|SLN (Silence Therapeutics) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti ProQR Therapeutics NV|Tezkor likvidlik Codexis, Inc. (CDXS)|Sangamo Therapeutics Inc. (SGMO) - Kritik likvidlik|Tezkor likvidlik koeffitsiyenti NAUT (Nautilus Bio)|Oraliq qoplama koeffitsiyenti Metagenomi Therapeutics (MGX)|Precision BioSciences, Inc. - Tezkor likvidlik koeffitsiyenti|GBIO - Tezkor likvidlik koeffitsiyenti|BOLD: Tezkor likvidlik koeffitsiyenti|Kritik likvidlik Exicure XCUR|IMNN (Imunon Inc) - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik RXi Pharmaceuticals PHIO|Tezkor likvidlik Mustang Bio, Inc. (MBIO)|transcodetherapeutics.com - Shoshilinch likvidlik koeffitsiyenti|Bionano Genomics - Tezkor likvidlik ko‘rsatkichi|Oraliq qoplash koeffitsiyenti APDN|BLUE - Tezkor likvidlik|IPA (ImmunoPrecise Antibodies) - Shoshilinch likvidlik koeffitsiyenti|OMGA (Omega Therapeutics) - Tezkor likvidlik ko‘rsatkichi|OMIC - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi RGLS|Tezkor likvidlik SYRS|Tezkor likvidlik ko‘rsatkichi TBIO (Codex DNA)|Oraliq qoplama koeffitsiyenti TRACON Pharmaceuticals, Inc|Tezkor likvidlik Unity Biotechnology UBX